title: Dopaminergic modulation of appetitive trace conditioning: the role of D1 receptors in medial prefrontal cortex.
abstract: BACKGROUND
  Trace conditioning may provide a behavioural model suitable to examine the maintenance of 'on line' information and its underlying neural substrates.
  
  
  OBJECTIVE
  Experiment la was run to establish trace conditioning in a shortened procedure which would be suitable to test the effects of dopamine (DA) D1 receptor agents administered by microinjection directly into the brain. Experiment lb examined the effects of the DA D1 agonist SKF81297 and the DA D1 antagonist SCH23390 following systemic administration in pre-trained animals. Experiment 2 went on to test the effects of systemically administered SKF81297 on the acquisition of trace conditioning. In experiment 3, SKF81297 was administered directly in prelimbic (PL) and infralimbic (IL) sub-regions of medial prefrontal cortex (mPFC) to compare the role of different mPFC sub-regions.
  
  
  RESULTS
  Whilst treatment with SCH23390 impaired motor responding and/or motivation, SKF81297 had relatively little effect in the pre-trained animals tested in experiment 1b. However, systemic SKF81297 depressed the acquisition function at the 2-s trace interval in experiment 2. Similarly, in experiment 3, SKF81297 (0.1 μg in 1.0 μl) microinjected into either PL or IL mPFC impaired appetitive conditioning at the 2-s trace interval.
  
  
  CONCLUSIONS
  Impaired trace conditioning under SKF81297 is likely to be mediated in part (but not exclusively) within the IL and PL mPFC sub-regions. The finding that trace conditioning was impaired rather than enhanced under SKF81297 provides further evidence for the inverse U-function which has been suggested to be characteristic of mPFC DA function.
authors.affiliation: School of Psychology, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
authors.forename: M A
authors.initials: MA
authors.lastname: Pezze
authors.forename: H J
authors.initials: HJ
authors.lastname: Marshall
authors.forename: H J
authors.initials: HJ
authors.lastname: Cassaday
mesh_terms: D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D003214:Conditioning, Classical / Q000187:drug effects*; D018491:Dopamine Agonists / Q000494:pharmacology*; D018492:Dopamine Antagonists / Q000494:pharmacology*; D008297:Male; D017397:Prefrontal Cortex / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D017447:Receptors, Dopamine D1 / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D001552:Benzazepines; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D017447:Receptors, Dopamine D1; C534628:SCH 23390; C067113:SK&F 81297
references.citation: J Psychopharmacol. 2008 Nov;22(8):849-59
references.pmid: 18208930
references.citation: J Neurosci. 1997 Nov 1;17(21):8528-35
references.pmid: 9334425
references.citation: Behav Brain Res. 2005 May 28;160(2):222-35
references.pmid: 15863219
references.citation: Psychopharmacology (Berl). 2002 Jun;161(4):425-33
references.pmid: 12073171
references.citation: J Psychopharmacol. 2004 Dec;18(4):516-26
references.pmid: 15582918
references.citation: J Psychopharmacol. 2003 Mar;17(1):67-76
references.pmid: 12680741
references.citation: Psychopharmacology (Berl). 1992;107(2-3):394-404
references.pmid: 1615139
references.citation: Neurobiol Learn Mem. 1998 Mar;69(2):147-62
references.pmid: 9619994
references.citation: J Pharmacol Exp Ther. 1997 Oct;283(1):183-9
references.pmid: 9336323
references.citation: Eur J Neurosci. 2001 Mar;13(5):1051-4
references.pmid: 11264679
references.citation: J Neurosci. 2014 Jun 4;34(23):7931-46
references.pmid: 24899715
references.citation: Learn Mem. 2006 Nov-Dec;13(6):728-33
references.pmid: 17142302
references.citation: Annu Rev Neurosci. 2009;32:267-87
references.pmid: 19555290
references.citation: Hippocampus. 2002;12(4):495-504
references.pmid: 12201634
references.citation: J Psychopharmacol. 2007 Jul;21(5):492-500
references.pmid: 16891340
references.citation: Behav Neurosci. 1986 Oct;100(5):729-44
references.pmid: 3778636
references.citation: Behav Neurosci. 2014 Feb;128(1):92-102
references.pmid: 24512069
references.citation: Int J Neuropsychopharmacol. 2012 Nov;15(10):1513-23
references.pmid: 22176724
references.citation: Neuroscience. 1981;6(2):177-87
references.pmid: 6111765
references.citation: Hippocampus. 2005;15(4):418-26
references.pmid: 15669102
references.citation: J Neural Transm Gen Sect. 1993;91(2-3):197-221
references.pmid: 8099797
references.citation: Behav Neurosci. 1995 Oct;109(5):819-27
references.pmid: 8554707
references.citation: J Neurosci. 1996 Aug 15;16(16):5154-67
references.pmid: 8756444
references.citation: Pharmacol Biochem Behav. 2002 Jun;72(3):723-8
references.pmid: 12175470
references.citation: Neurobiol Learn Mem. 2011 Sep;96(2):181-91
references.pmid: 21514394
references.citation: Trends Cogn Sci. 1998 Nov 1;2(11):436-47
references.pmid: 21227275
references.citation: Front Syst Neurosci. 2014 Sep 08;8:160
references.pmid: 25249948
references.citation: Nature. 2000 May 18;405(6784):347-51
references.pmid: 10830963
references.citation: J Neurosci. 2004 Feb 11;24(6):1288-95
references.pmid: 14960599
references.citation: Behav Neurosci. 2008 Aug;122(4):841-8
references.pmid: 18729637
references.citation: Neurobiol Learn Mem. 2001 Nov;76(3):447-61
references.pmid: 11726247
references.citation: Adv Med Sci. 2011;56(1):71-9
references.pmid: 21515488
references.citation: Psychopharmacology (Berl). 2004 Jun;174(1):99-110
references.pmid: 15205881
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13473-80
references.pmid: 8942959
references.citation: Neurobiol Learn Mem. 2010 Jan;93(1):37-45
references.pmid: 19682591
references.citation: J Neurosci. 2000 Feb 1;20(3):1208-15
references.pmid: 10648725
references.citation: Brain Res. 2004 Jan 2;995(1):55-65
references.pmid: 14644471
references.citation: Hippocampus. 2000;10(6):739-51
references.pmid: 11153719
references.citation: Exp Brain Res. 2000 Jul;133(1):23-32
references.pmid: 10933207
references.citation: Behav Neurosci. 2002 Feb;116(1):37-47
references.pmid: 11895181
references.citation: Behav Neurosci. 2000 Feb;114(1):3-17
references.pmid: 10718258
references.citation: Ann Neurosci. 2010 Jul;17(3):136-41
references.pmid: 25205891
references.citation: Trends Cogn Sci. 2003 Sep;7(9):415-423
references.pmid: 12963473
references.citation: Trends Neurosci. 2014 Aug;37(8):455-64
references.pmid: 24929864
references.citation: Behav Neurosci. 1990 Apr;104(2):243-52
references.pmid: 2346619
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13087-92
references.pmid: 14555761
references.citation: Synapse. 2002 Jul;45(1):38-45
references.pmid: 12112412
references.citation: Behav Neurosci. 2000 Dec;114(6):1058-67
references.pmid: 11142638
references.citation: Behav Neurosci. 2005 Dec;119(6):1496-510
references.pmid: 16420154
references.citation: Psychopharmacology (Berl). 1994 Oct;116(2):143-51
references.pmid: 7862943
references.citation: J Pharmacol Exp Ther. 2001 May;297(2):501-8
references.pmid: 11303036
references.citation: Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1325-9
references.pmid: 8577763
references.citation: Psychol Med. 1994 Nov;24(4):849-57
references.pmid: 7892353